000 01792 a2200445 4500
005 20250511175836.0
264 0 _c19920407
008 199204s 0 0 eng d
022 _a0027-8424
024 7 _a10.1073/pnas.89.5.1978
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aXu, H
245 0 0 _aOpioid enhancement of evoked [Met5]enkephalin release requires activation of cholinergic receptors: possible involvement of intracellular calcium.
_h[electronic resource]
260 _bProceedings of the National Academy of Sciences of the United States of America
_cMar 1992
300 _a1978-82 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _a3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer
650 0 4 _aAnimals
650 0 4 _aAtropine
_xpharmacology
650 0 4 _aCalcimycin
_xpharmacology
650 0 4 _aCalcium
_xphysiology
650 0 4 _aColforsin
_xpharmacology
650 0 4 _aEnkephalin, D-Penicillamine (2,5)-
650 0 4 _aEnkephalin, Methionine
_xmetabolism
650 0 4 _aEnkephalins
_xpharmacology
650 0 4 _aEvoked Potentials
650 0 4 _aFentanyl
_xanalogs & derivatives
650 0 4 _aGuinea Pigs
650 0 4 _aHexamethonium Compounds
_xpharmacology
650 0 4 _aIn Vitro Techniques
650 0 4 _aMyenteric Plexus
_xphysiology
650 0 4 _aNaloxone
_xpharmacology
650 0 4 _aPyrrolidines
_xpharmacology
650 0 4 _aReceptors, Muscarinic
_xphysiology
650 0 4 _aReceptors, Opioid
_xdrug effects
650 0 4 _aSufentanil
700 1 _aGintzler, A R
773 0 _tProceedings of the National Academy of Sciences of the United States of America
_gvol. 89
_gno. 5
_gp. 1978-82
856 4 0 _uhttps://doi.org/10.1073/pnas.89.5.1978
_zAvailable from publisher's website
999 _c1318381
_d1318381